PharmaBioSource Realty provided real estate services to Shire on the divestment of the assets in its 58,000 SF Hayward, California mammalian cell culture drug substance pilot plant facility to Lonza.

• Service: Real Estate
• Sector: Biotechnology
• Sub-sector: Mammalian Cell Culture Drug Substance
• Engagement Type: Sell Side

PharmaBioSource Realty provided exclusive life sciences real estate services to divest Shire’s mammalian cell culture drug substance pilot plant assets near San Francisco, CA.

The assets were acquired by the global CDMO Lonza to expand its development and clinical scale manufacturing presence in the U.S.  In addition to the purchase of the assets, Lonza assumed the lease for the facility which housed multiple 1,000L and 2,000L bioreactors. PharmaBioSource’s services included a benchmark valuation, buyer target identification, creation of the confidential information memorandum (CIM), data room development and due diligence support.

Press Release